Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
Published 25 October 2019 The current study supports the usage of gene expression signatures in specific clinical treatment groups within population-based breast cancer. It also stresses the need of further development to reach higher consensus in individual patient classifications, especially for intermediate-risk patients, and the targeting of patients where current gene signatures and prognosti